Work

Rapid Intracranial Response to Zongertinib in HER2-mutated Adenocarcinoma

Year: 2026
Type: article
Study design: Case Report
Abstract: Figure.An 81-year-old man was diagnosed three years earlier with HER2 exon 20 insertion-mutated lung adenocarcinoma (cT4N3M1c, stage IVB).During chemotherapy, multiple new brain metastases were observed (Picture A and C), accompanied by the complete paralysis of his right upper extremity (manual muscle testing [MMT] grade 0).As a fifth-line therapy, zongertinib was initiated at 120 mg/day three days after the completion of stereotactic radiotherapy for the brain metastases (32.5 Gy in five fractions).His paralysis improved to MMT grade 3 within 12 days, and brain MRI demonstrated
Institution: Oita University
Language: English
Field: Medicine
Open Access status: diamond
OpenAlex ID: W7236004856
FWCI:
Cites: 2
Cited by:
Related to: 10